AbbVie Stock Pulls Back After Six-Day Win Streak Ends
AbbVie shares slipped after a strong six-session run, signaling a potential short-term reset for traders watching the pharma giant.
AbbVie had a good run — six straight sessions of gains — and now the stock is taking a breather. That kind of streak in a large-cap pharma name draws attention, and the pullback that followed is exactly the kind of setup active traders watch for after momentum peaks.
When a stock strings together six winning sessions, it often means short-term buyers are loaded up and profit-taking becomes the path of least resistance. That's not a fundamental story changing — it's just the market doing what it does. AbbVie's underlying business hasn't shifted overnight.
Read more Cramer's 10 Stock Market Movers to Watch Tuesday →
For swing traders, the question now is whether this dip is a buying opportunity or the start of a deeper correction. Support levels from the prior consolidation zone matter here. If volume on the down day was light, that's a healthier sign than a heavy sell-off with conviction behind it.
Long-term holders in AbbVie have gotten used to volatility, especially as the company navigates its post-Humira revenue transition. Short-term noise like a single down day after a six-session rally doesn't change the thesis for patient investors sitting on dividend income.
Watch the next two or three sessions closely. How AbbVie reacts at key technical levels will tell you a lot more than one red candle after a solid run. Continue reading at SeekingAlpha.
